OptimizeRx Corp Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2015 to Q2 2025
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
OptimizeRx Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2015 to Q2 2025.
- OptimizeRx Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 19M shares, a 4.15% increase year-over-year.
- OptimizeRx Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 18.3M shares, a 6.82% increase from 2023.
- OptimizeRx Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 17.1M shares, a 3.71% decline from 2022.
- OptimizeRx Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 17.8M shares, a 0.53% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)